Acute respiratory distress syndrome as the initial symptom of hepatic angiosarcoma with Kasabach–Merritt syndrome: A case report

Xiaoqian Cui,Min Zhang,Debiao Song,Jiakun Tian
DOI: https://doi.org/10.1097/md.0000000000039800
IF: 1.6
2024-09-29
Medicine
Abstract:Hepatic angiosarcoma (HSA) is a sporadic tumor originating from endothelial cells in the liver. It represents approximately 5% of all angiosarcomas and accounts for 0.1% to 2% of liver malignancies. It is characterized by highly aggressive behaviors and rapid progression. [ 1 , 2 ] Reports indicate that among the postoperative pathological results of 1500 cases of surgical resection for adults' primary hepatic tumors, only 2 cases were confirmed to be HAS. [ 3 ] Unfortunately, HSA is often misdiagnosed or overlooked due to the absence of typical clinical symptoms or specific markers. Most patients lack typical symptoms. According to reports, when the tumor exceeds 5 cm in size, patients may experience abdominal discomfort or pain. However, even at this stage, HSA still does not present significant abnormalities in laboratory indicators. [ 4 ] A definitive diagnosis requires a pathological examination of the biopsy tissue. [ 5 ] The main treatment methods include surgery, adjuvant chemotherapy, transcatheter embolization (TAE), and transarterial chemoembolization. In some reports, teams have attempted to treat HSA using partial hepatectomy or liver transplantation. However, the postoperative survival period of patients often does not exceed 1 year. [ 3 , 6 ] HSA has an overall poor outcome. Despite existing studies and case reports, [ 7 , 8 ] the understanding of the disease's clinical characteristics, diagnostic criteria, treatment strategies, and prognosis remains limited.
medicine, general & internal
What problem does this paper attempt to address?